Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.96 |
| ▸ | PPARG | P37231 | 5/20 | 0.81 |
| ▸ | PPARD | Q03181 | 5/20 | 0.81 |
| ▸ | PPARA | Q07869 | 5/20 | 0.81 |
| ▸ | F7 | P08709 | 5/20 | 0.81 |
| ▸ | F3 | P13726 | 5/20 | 0.81 |
| ▸ | TERT | O14746 | 3/20 | 0.81 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.81 |
| ▸ | FABP4 | P15090 | 3/20 | 0.81 |
| ▸ | MAPT | P10636 | 2/20 | 0.81 |
| ▸ | BLM | P54132 | 2/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.81 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.81 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.81 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.81 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.81 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.81 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1647674 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL2230814 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1017653 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL23698235 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL37277 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL23698236 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL16994321 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1647672 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL3399216 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1017655 | 1.00 | FASN (0.96) | FASNPPARGPPARDPPARAF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009032699-A1 | ANTI-PROLIFERATIVE COMBINATIONS | DRUGTECH CORPORATION (US) | 2009-03-12 | — | — | WO | claimed |
| US-20090068190-A1 | ANTI-PROLIFERATIVE COMBINATIONS | DRUGTECH CORPORATION (US) | 2009-03-12 | — | — | US | claimed |
| US-20260144834-A1 | ANTIMICROBIAL FEED ADDITIVE | Axitan Ltd. (GB) | 2026-05-28 | — | — | US | disclosed |
| US-12471609-B2 | Reducing the risk of viral infection due to viral contaminated feed | NOVUS INTERNATIONAL, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250177439-A1 | LOW DOSE PRE-MIX FEED FOR TRACE MINERAL SUPPLEMENTATION | Chemlock Operating LLC d/b/a Chemlock Nutrition (US) | 2025-06-05 | — | — | US | disclosed |
| US-12310386-B2 | Reducing the risk of viral infection due to viral contaminated feed | NOVUS INTERNATIONAL, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| US-20250008984-A1 | REDUCING THE RISK OF VIRAL INFECTION DUE TO VIRAL CONTAMINATED FEED | NOVUS INTERNATIONAL, INC. | 2025-01-09 | — | — | US | disclosed |
| US-20230165275-A1 | REDUCING THE RISK OF VIRAL INFECTION DUE TO VIRAL CONTAMINATED FEED | NOVUS INTERNATIONAL, INC. | 2023-06-01 | — | — | US | disclosed |
| US-11564405-B2 | Reducing the risk of viral infection due to viral contaminated feed | NOVUS INTERNATIONAL, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| EP-3328199-B1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | NOVUS INT INC (US) | 2022-03-23 | — | — | EP | disclosed |
| EP-3934627-A1 | REDUCING THE RISK OF VIRAL INFECTION DUE TO VIRAL CONTAMINATED FEED | Novus International Inc. (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20100297254-A1 | NUTRACEUTICAL COMPOSITION AND METHODS OF USE | DACY TECH PTY LTD (AU) | 2010-11-25 | — | — | US | disclosed |
| EP-2240190-A1 | NUTRACEUTICAL COMPOSITION AND METHODS OF USE | Dacy Tech Pty Ltd (AU) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009073931-A1 | NUTRACEUTICAL COMPOSITION AND METHODS OF USE | DACY TECH PTY LTD (AU) | 2009-06-18 | — | — | WO | disclosed |
| US-20090124574-A1 | Carotenoid analogs and derivatives for the prevention of platelet aggregation | CARDAX PHARMA, INC. | 2009-05-14 | — | — | US | disclosed |
| US-20090099061-A1 | SYNTHESIS OF CAROTENOID ANALOGS OR DERIVATIVES WITH IMPROVED ANTIOXIDANT CHARACTERISTICS | CARDAX PHARMACEUTICALS, INC. | 2009-04-16 | — | — | US | disclosed |
| WO-2009032699-A1 | ANTI-PROLIFERATIVE COMBINATIONS | DRUGTECH CORPORATION (US) | 2009-03-12 | — | — | WO | disclosed |
| US-20090068190-A1 | ANTI-PROLIFERATIVE COMBINATIONS | DRUGTECH CORPORATION (US) | 2009-03-12 | — | — | US | disclosed |
| WO-2008118862-A1 | CAROTENOID ANALOGS AND DERIVATIVES FOR THE PREVENTION OF PLATELET AGGREGATION | CARDAX PHARMACEUTICALS, INC. (US) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008106606-A2 | CAROTENOID ANALOGS AND DERIVATIVES IN THE TREATMENT OF PROSTATE CANCER | CARDAX PHARMACEUTICALS, INC. (US) | 2008-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144834-A1 | ANTIMICROBIAL FEED ADDITIVE | ELOVL6, CROCC, ELOC | FASN 319/4885PPARG 1938/4885PPARD 1774/4885 |
| US-20090068190-A1 | ANTI-PROLIFERATIVE COMBINATIONS | FOLR2, FOLR1, DHFR | FASN 13/4885PPARG 164/4885PPARD 166/4885 |
| US-20090124574-A1 | Carotenoid analogs and derivatives for the prevention of platelet aggregation | PROC, PFKP, PF4 | FASN 1170/4885PPARG 386/4885PPARD 206/4885 |
| US-20090099061-A1 | SYNTHESIS OF CAROTENOID ANALOGS OR DERIVATIVES WITH IMPROVED ANTIOXIDANT CHARACTERISTICS | CAT, HBZ, POLL | FASN 231/4885PPARG 633/4885PPARD 684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.